|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01276 HENGRUI PHARMA
Nominal 
57.550 +0.600 (+1.054%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 27,984,605 | 22.633% | 22,819,785 | 21,275,271 |
| Cost of Sales | (3,848,177) | 9.160% | (3,525,248) | (3,486,639) |
| Gross Profit | 24,136,428 | 25.095% | 19,294,537 | 17,788,632 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (21,581) | -70.313% | (72,696) | (62,996) | |
| Profit / (Loss) before Taxation | 7,169,690 | 53.622% | 4,667,110 | 3,968,492 | |
| Taxation | (832,695) | 113.901% | (389,289) | (153,351) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | (468) | -- | 24,615 | 91,233 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 6,336,527 | 47.278% | 4,302,436 | 3,906,374 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (597,718) | 26.840% | (471,238) | (378,784) |
| Depreciation & Amortisation | 870,819 | 9.684% | 793,937 | 640,511 |
| Directors' Emoluments | 25,945 | 27.069% | 20,418 | 10,537 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| EPS (cts) | 100.000 | 47.059% | 68.000 | 61.000 |
| DPS (cts) | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | 1.169 | -- | 1.202 | 0.198 |
| NBV per share ($) | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 06/06/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 6,336,527 |
| %Change | 47.278% |
| EPS / (LPS) | RMB 1.000 |
| NBV Per Share (¥) | RMB -- |